Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist

Proceedings of the National Academy of Sciences of the United States of America
James G PfausP B Molinoff

Abstract

Disorders of sexual desire affect an estimated 30% of women in North America and Europe, with etiologies based on interpersonal, personal, and physiological factors. There are currently no pharmacological agents approved for use in the treatment of female sexual dysfunction. This is due, in part, to a focus on the effects of experimental drugs on reflexive components of sexual behavior, such as lordosis, in animal models. Here we report that PT-141, a peptide analogue of alpha-melanocyte-stimulating hormone that binds to central melanocortin receptors, selectively stimulates solicitational behaviors in the female rat. This occurs without affecting lordosis, pacing, or other sexual behaviors. PT-141 did not cause generalized motor activation, nor did it affect the perception of sexual reward. A selective pharmacological effect on appetitive sexual behavior in female rats has not been reported previously, and indicates that central melanocortin systems are important in the regulation of female sexual desire. Accordingly, PT-141 may be the first identified pharmacological agent with the capability to treat female sexual desire disorders.

References

Jan 1, 1989·Neuroscience and Biobehavioral Reviews·W A Dornan, C W Malsbury
Jan 1, 1987·Neuroscience and Biobehavioral Reviews·J G Pfaus, B B Gorzalka
Feb 1, 1997·Behavioral Neuroscience·R G Paredes, A Alonso
Dec 21, 2000·Current Psychiatry Reports·R C Rosen
Feb 22, 2001·Hormone Research·H StichelA Grüters
Jul 10, 2003·Annals of the New York Academy of Sciences·P B MolinoffC Y Quon
Feb 21, 2004·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Karen DybkaerPoul H Jørgensen

❮ Previous
Next ❯

Citations

Dec 21, 2006·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Uwe Hartmann, C Rüffer-Hesse
Mar 14, 2009·Psychopharmacology·Veronica M AfonsoJames G Pfaus
Oct 19, 2006·World Journal of Urology·Stefan UckertChristian G Stief
Dec 5, 2008·European Archives of Psychiatry and Clinical Neuroscience·Claus Normann, Mathias Berger
Jul 16, 2013·Progress in Neurobiology·Antonio Argiolas, Maria Rosaria Melis
Jun 17, 2008·International Journal of Impotence Research·A M Shadiack, S Althof
Mar 8, 2008·Nature Reviews. Drug Discovery·Jarl E S Wikberg, Felikss Mutulis
Nov 17, 2007·Current Opinion in Obstetrics & Gynecology·Margit E MayerStefan Uckert
Jan 1, 2012·Socioaffective Neuroscience & Psychology·Genaro A Coria-Avila
Jul 1, 2013·Sexual Medicine Reviews·Lesley MarsonUrsula Wesselmann
Nov 21, 2007·The Journal of Sexual Medicine·James PfausHélène Gelez
Jul 9, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·F CourF Giuliano
May 21, 2009·The Journal of Sexual Medicine·James G Pfaus
Jan 28, 2009·The Journal of Sexual Medicine·Lesley A WilsonV Margaret Jackson
Nov 6, 2010·The Journal of Sexual Medicine·Francois GiulianoKim Wallen
Feb 2, 2008·The Journal of Sexual Medicine·James Pfaus
Oct 30, 2010·The Journal of Sexual Medicine·Arthur L BurnettZhong C Xin
Feb 21, 2013·The Journal of Sexual Medicine·Hélène GelezFrançois Giuliano
Oct 5, 2010·Journal of Chemical Neuroanatomy·Helene GelezFrançois Giuliano
Mar 9, 2010·Molecular and Cellular Endocrinology·Davids FridmanisJanis Klovins
Jun 26, 2007·Pharmacology, Biochemistry, and Behavior·Hassan H LópezBenjamin Ragen
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Irwin Goldstein
Feb 9, 2006·British Journal of Pharmacology·Gordon McMurrayAlasdair M Naylor
Jul 5, 2005·Peptides·H WessellsT W Vanderah
May 9, 2012·Pharmacology, Biochemistry, and Behavior·Tamara Cibrian-LlanderalGenaro A Coria-Avila
Jul 23, 2011·Physiology & Behavior·Pedro Paredes-RamosGenaro A Coria-Avila
Dec 20, 2011·Physiology & Behavior·Sara C SagaeGilberto L Sanvitto
Jan 6, 2009·International Review of Cell and Molecular Biology·Sara AspengrenMargareta Wallin
Mar 4, 2005·The Journal of Pharmacology and Experimental Therapeutics·Sarah A NickollsRich A Maki
Oct 11, 2019·Obstetrics and Gynecology·Sheryl A KingsbergJames A Simon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacology, Biochemistry, and Behavior
Anne-Sophie RösslerFrançois Giuliano
Annals of the New York Academy of Sciences
P B MolinoffC Y Quon
Proceedings of the National Academy of Sciences of the United States of America
Lex H T Van der PloegD Euan MacIntyre
© 2022 Meta ULC. All rights reserved